Malaria Vaccine Rollout Accelerates Across Africa as New Innovations Combat Supply Shortages and Funding Challenges

About this episode

The episode discusses the accelerated rollout of malaria vaccines across Africa amidst funding cuts and supply shortages.

Recent developments in malaria control highlight the expanding rollout of approved vaccines amid ongoing challenges like funding cuts and supply shortages. As of January 28, 2026, Gavi reports that 25 African countries have integrated malaria vaccines into routine immunization programs with its support, building on the WHO-endorsed RTS,S (Mosquirix) and R21 shots, which reduce child cases by over 50 percent in the first year after dosing. In Nigeria, Bauchi State Government flagged off a major March immunization drive through its Primary Healthcare Development Board, targeting polio and malaria vaccines for two million children under five, signaling accelerated local deployment. Tropical Health Matters notes sustained gains since 2019 in Kenya's Malaria Vaccine Implementation Programme (MVIP), where RTS,S, developed over 35 years by GlaxoSmithKline with WHO, Gavi, and PATH backing, has cut deaths and hospitalizations in young children. Yet hurdles persist. The same source warns of U.S. funding suspension projecting 12.5 to 17.9 million extra cases and 71,000 to 166,000 deaths this year, straining supplies—six endemic countries have under three months of rapid diagnostic tests…

Topics covered

• malaria vaccine rollout
• healthcare challenges
• immunization programs
• vaccine efficacy
• funding issues
• supply shortages
• vaccine hesitancy

Keywords

• malaria
• vaccine
• Africa
• immunization
• funding
• supply chain
• healthcare
• RTS,S
• R21
• vaccine hesitancy

Mentioned in this episode

Organizations: Gavi, WHO, GlaxoSmithKline, PATH, UNICEF

Products: RTS,S (Mosquirix), R21

Places: Nigeria, Bauchi State, Kenya

More episodes of Malaria Vaccine

• **Next-Generation Malaria Vaccine R78C Offers Hope as Global Cases Rise to 282 Million** · May 5, 2026 · 4 min
• Oxford and Serum Institute Launch R78C Next-Generation Malaria Vaccine to Transform Treatment Across Africa · May 3, 2026 · 2 min
• Malaria Vaccine Updates: Where to Find the Latest News and Official Health Resources · May 1, 2026 · 1 min
• Malaria Vaccines Transform Africa: 32% Case Drop in Burkina Faso Despite Funding and Misinformation Challenges · April 28, 2026 · 2 min
• R21 Malaria Vaccine Dramatically Cuts Cases and Deaths Across Africa, But Funding Gaps and Misinformation Threaten Progress · April 26, 2026 · 2 min
• Malaria Vaccine Rollout Stalled by Funding Cuts and Misinformation Despite Scientific Breakthroughs · April 24, 2026 · 4 min